Explore

Communities in English

Advertise on Engormix

Mycotoxin-deactivator:In vitro or In vivo, How should we choose?

Published: April 29, 2022
Evaluating the effect of a mycotoxin-deactivator can be quite challenging. How should we choose between in vitro and in vivo?
Related topics:
Authors:
Margaux Lecolinet
Adisseo
Vito D’Ascanio
Institute of Sciences of Food Production ISPA
Institute of Sciences of Food Production ISPA
Recommend
Comment
Share
Swamy Haladi
Trouw Nutrition
20 de septiembre de 2022
Dr. Marchenkov, in relation to your question on binders binding vitamins, please keep in mind that today customers are using maximum of 2 kg per ton of feed toxin binder. I won't recommend anything more than that. At such levels of inclusion, vitamin binding is zero or very minimal. 70% of the global feed today contains one or other mycotoxin binder. Very rarely we get questions from customers on nutrient binding. There was a time when customers were using 5 kg per ton clay binders. Those days are gone. More than nutrient binding, the customers need to evaluate technical dossier of the product related to in vitro or in vivo binding as well as performance benefits. Research has shown significant impact of almost all the mycotoxins on gut and immune systems in animals. We need to make sure the product helps in reinstating these organ systems. Mycotoxin binding concept alone will not help to manage all the mycotoxins we know today. I hope this helps. Regards, Swamy
Recommend
Reply
Ram Singh
3 de agosto de 2022
For poultry we should choose In Vivo. However for ruminants, we should try both In Vitro as well as In Vivo. Dr Ram Singh Bibyan
Recommend
Reply
Ram Singh
6 de junio de 2022
For poultry, I have formulated two mycotoxin binders namely Mycodetox B1 and Mycodetox B2 based on my decade's research on chickens, quails, turkeys and ducks. Both the binders ameliorated the adverse effects of aflatoxicosis in poultry and are equally efficaceous in ameliorating aflatoxicosis in these poultry species. Dr. Ram Singh Bibyan
Recommend
Reply
Fernando Tamames
Special Nutrients
5 de mayo de 2022
Dear All It is surprising that in 2022 we are making questions that were resolved in 1987 /1988 In vitro trials will never prove that a product will work in vivo. This was proven in 1988 with Activated Charcoal it captured 100% of the mycotoxin in vitro but it did not work in vivo protecting the target organ. Deactivation - Biotransformation - Adsorption The best explanation is the rumen of a cow. A rumen can biotransformation and/or deactivate mycotoxin as long as you have perfect conditions When stress, acidosis, use of antibiotics, bacterial infections, not well balance feed ocurre this biotransformation / deactivation is reduced significantly. In the case of adsorption the same way that the clay comes in the same way that the clay com out and it is not affected by conditions in the GI tract. The key factor on adsorption is the quality , type and process that is done to the clay so it is capable of adsorbing one and or multiple toxins. Also you need to differentiate products that reduce the secondary effect caused by a mycotoxin vs product that by adsorbing the mycotoxin are capable of Protecting the Target organ that the mycotoxin affects. This is the only way to differentiate true mycotoxin binders vs hepatoprotections , immunomodulators, probiotics that improve productivity parameters but do not protect the target organs. etc.
Recommend
Reply
Dr. Fiodor S. Marchenkov
Kronos -Agro private company
4 de mayo de 2022
Dear all, at first we need to select: what is deactivation? Is it destroying? Or binding? Or we need to know how effective is liver P-450 in vivo against mycotoxins? How can we use binders if these binders can chemically react with vitamins? What is alternative? Grain without mycotoxins: is it possible? Probably not, and this is problem for everybody. Let's discuss!
Recommend
Reply
Shirin farsad
25 de julio de 2022
Hi. I think the best toxin binder : 1- High absorption power 2-High degree of purity 3-price is right 4- less side effects on host health
Recommend
Reply
Jonathan Tarus
17 de mayo de 2022

The main goal is to minimize / avoid mycotoxin effects to consumers, thus we should target/point forward to methods which can achieve this goal. Either prevention from the source or deactivation after contamination. This will involve intense research on, say, deactivators under different environmental conditions to ascertain the effectiveness. This means it should be tested both in vitro and in vivo then we make a choice / choices.

Recommend
Reply
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Mycotoxins
Don Giesting
Don Giesting
Cargill
Biz Dev Mgr/Cargill
United States
Bart Dunsford
Bart Dunsford
DSM-Firmenich
United States
Enrique Angulo Cedeño
Enrique Angulo Cedeño
MSD - Merck Animal Health
United States
Join Engormix and be part of the largest agribusiness social network in the world.